As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Pfizer Inc. (NYSE: PFE, "Pfizer") will present data across its infectious disease portfolio at the upcoming IDWeek 2025 ...

Market Catalysts host Julie Hyman and Yahoo Finance senior reporter Brooke DiPalma track several of the day's top trending ...

The company recently announced an acquisition that will bolster its growth prospects in the GLP-1 obesity market.

SureCare Pharmacy manager Oscar Uribe shows off a package of Pfizer Paxlovid pills inside of Esperanza Health Center in Chicago on Jan. 13, 2022. Pfizer's Paxlovid is a treatment for COVID-19. (Chris ...

Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty over whether a rollout ...

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...

Trump and Pfizer said they reached a landmark deal to cut drug prices. Most Americans won't see a benefit, but Pfizer will.